SCHEMBL4186933

SCHEMBL4186933

O=P(O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O.Oc1cc(O)c(O)c(O)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.38
FDPS P14324 1/20 0.38
BLM P54132 1/20 0.38
INPPL1 O15357 4/20 0.34
INPP5A Q14642 2/20 0.34
INPP5B P32019 1/20 0.34
BTN3A1 O00481 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TTR P02766 1/20 0.31
CYP1A1 P04798 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
HSPD1 P10809 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MAOA P21397 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4172265 1.00 TDP1 (0.38) TDP1FDPSBLMINPPL1INPP5A
SCHEMBL4181366 0.86 FDPS (0.50) TDP1FDPSBLMINPPL1INPP5A
SCHEMBL4186927 0.85 INPPL1 (0.36) TDP1FDPSBLMINPPL1INPP5A
SCHEMBL4172260 0.85 INPPL1 (0.36) TDP1FDPSBLMINPPL1INPP5A
Phosphoric Acid SCHEMBL4172263 0.78 KDM4E (0.38) TDP1BLMINPPL1INPP5AINPP5B
Triphosphate SCHEMBL4186099 0.77 FDPS (0.45) TDP1FDPSBLMINPPL1INPP5A
SCHEMBL8851949 0.75 FDPS (0.64) TDP1FDPSBLMBTN3A1
SCHEMBL554667 0.75 FDPS (0.64) TDP1FDPSBLMBTN3A1
SCHEMBL45357 0.75 FDPS (0.64) TDP1FDPSBLMBTN3A1
SCHEMBL897837 0.75 FDPS (0.64) TDP1FDPSBLMBTN3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090098589-A1 Method DUPONT NUTRITION BIOSCIENCES APS (DK) 2009-04-16 US claimed
JP-2008545385-A 2008-12-18 JP claimed
EP-1888771-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2008-02-20 EP claimed
WO-2006123254-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2006-11-23 WO claimed
US-20090098589-A1 Method DUPONT NUTRITION BIOSCIENCES APS (DK) 2009-04-16 US disclosed
EP-1888771-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2008-02-20 EP disclosed
WO-2006123254-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090098589-A1 Method ALPL, PPA1, ITPA TDP1 1661/4885FDPS 176/4885BLM 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.